6k25 - Revision history

OCA at 10:25, 22 November 2023

OCA — Wed, 22 Nov 2023 10:25:47 GMT

←Older revision		Revision as of 10:25, 22 November 2023
Line 3:		Line 3:
	<StructureSection load='6k25' size='340' side='right'caption='[[6k25]], [[Resolution\|resolution]] 2.40Å' scene=''>		<StructureSection load='6k25' size='340' side='right'caption='[[6k25]], [[Resolution\|resolution]] 2.40Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[6k25]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K25 OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=6K25 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6k25]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K25 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6K25 FirstGlance]. <br>
-	</td></tr><tr id='~~related~~'><td class="sblockLbl"><b>[[~~Related_structure~~\|~~Related~~:]]</b></td><td class="sblockDat">[[~~6k22~~\|~~6k22~~]]</td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.401Å</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=6k25 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k25 OCA], [~~http~~://pdbe.org/6k25 PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6k25 RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6k25 PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6k25 ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6k25 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k25 OCA], [https://pdbe.org/6k25 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6k25 RCSB], [https://www.ebi.ac.uk/pdbsum/6k25 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6k25 ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/ANXA5_HUMAN ANXA5_HUMAN]] Defects in ANXA5 are associated with susceptibility to pregnancy loss, recurrent, type 3 (RPRGL3) [MIM:[~~http~~://omim.org/entry/614391 614391]]. A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions.<ref>PMID:17339269</ref>	+	[https://www.uniprot.org/uniprot/ANXA5_HUMAN ANXA5_HUMAN] Defects in ANXA5 are associated with susceptibility to pregnancy loss, recurrent, type 3 (RPRGL3) [MIM:[https://omim.org/entry/614391 614391]. A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions.<ref>PMID:17339269</ref>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/ANXA5_HUMAN ANXA5_HUMAN]] This protein is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade.	+	[https://www.uniprot.org/uniprot/ANXA5_HUMAN ANXA5_HUMAN] This protein is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade.
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 20:		Line 20:
	</div>		</div>
	<div class="pdbe-citations 6k25" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 6k25" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Annexin 3D structures\|Annexin 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Ha, N C]]	+	[[Category: Ha N-C]]
-	[[Category: Hong, S]]	+	[[Category: Hong S]]
-	~~[[Category: Annexin a5]]~~	+
-	~~[[Category: Anxa5]]~~	+
-	~~[[Category: Lipid binding protein]]~~	+
-	~~[[Category: Membrane repair]]~~	+
-	~~[[Category: Phospholipid binding~~]]	+

OCA at 10:04, 27 March 2020

OCA — Fri, 27 Mar 2020 10:04:04 GMT

←Older revision		Revision as of 10:04, 27 March 2020
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6k25 is ~~ON HOLD~~ until ~~Paper~~ Publication	+	==Crystal structure of Ca-unbound human Annexin A5 in low salt condition==
		+	<StructureSection load='6k25' size='340' side='right'caption='[[6k25]], [[Resolution\|resolution]] 2.40Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[6k25]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K25 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6K25 FirstGlance]. <br>
		+	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[6k22\|6k22]]</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6k25 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k25 OCA], [http://pdbe.org/6k25 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6k25 RCSB], [http://www.ebi.ac.uk/pdbsum/6k25 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6k25 ProSAT]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/ANXA5_HUMAN ANXA5_HUMAN]] Defects in ANXA5 are associated with susceptibility to pregnancy loss, recurrent, type 3 (RPRGL3) [MIM:[http://omim.org/entry/614391 614391]]. A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions.<ref>PMID:17339269</ref>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/ANXA5_HUMAN ANXA5_HUMAN]] This protein is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade.
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Annexins are soluble cytosolic proteins that bind to cell membranes. Annexin A5 self-assembles into a two-dimensional (2D) array and prevents cell rupture by attaching to damaged membranes. However, this process is not fully understood at the molecular level. In this study, we determined the crystal structures of annexin A5 with and without calcium (Ca(2+)) and confirmed the Ca(2+)-dependent outward motion of a tryptophan residue. Strikingly, the two structures exhibited the same crystal packing and 2D arrangement into a p3 lattice, which agrees well with the results of low-resolution structural imaging. High-resolution structures indicated that a three-fold interaction near the tryptophan residue is important for mediating the formation of the p3 lattice. A hypothesis on the promotion of p3 lattice formation by phosphatidyl serine (PS) is also suggested. This study provides molecular insight into how annexins modulate the physical properties of cell membranes as a function of Ca(2+) concentration and the phospholipid composition of the membrane.

-	~~Authors:~~ Hong, S., Ha, N.-C.	+	High-resolution structures of annexin A5 in a two-dimensional array.,Hong S, Na S, Kim OH, Jeong S, Oh BC, Ha NC J Struct Biol. 2020 Jan 1;209(1):107401. doi: 10.1016/j.jsb.2019.10.003. Epub, 2019 Oct 9. PMID:31605770<ref>PMID:31605770</ref>

-	~~Description: Crystal structure~~ of Ca-~~unbound human Annexin A5 in low salt condition~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased~~ Structures]]	+	</div>
-	[[Category: Ha, N.-C]]	+	<div class="pdbe-citations 6k25" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Ha, N C]]
	[[Category: Hong, S]]		[[Category: Hong, S]]
		+	[[Category: Annexin a5]]
		+	[[Category: Anxa5]]
		+	[[Category: Lipid binding protein]]
		+	[[Category: Membrane repair]]
		+	[[Category: Phospholipid binding]]

OCA: Protected "6k25" [edit=sysop:move=sysop]

OCA — Wed, 22 May 2019 03:54:33 GMT

Protected "6k25" [edit=sysop:move=sysop]

←Older revision

Revision as of 03:54, 22 May 2019

OCA: New page: '''Unreleased structure''' The entry 6k25 is ON HOLD until Paper Publication Authors: Hong, S., Ha, N.-C. Description: Crystal structure of Ca-unbound human Annexin A5 in low salt cond...

OCA — Wed, 22 May 2019 03:54:32 GMT

New page: '''Unreleased structure''' The entry 6k25 is ON HOLD until Paper Publication Authors: Hong, S., Ha, N.-C. Description: Crystal structure of Ca-unbound human Annexin A5 in low salt cond...

New page

'''Unreleased structure'''

The entry 6k25 is ON HOLD until Paper Publication

Authors: Hong, S., Ha, N.-C.

Description: Crystal structure of Ca-unbound human Annexin A5 in low salt condition
[[Category: Unreleased Structures]]
[[Category: Ha, N.-C]]
[[Category: Hong, S]]